methylprednisolone acetate has been researched along with Atrophy in 2 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beyzadeoglu, T | 1 |
Bekler, H | 1 |
Gokce, A | 1 |
Shields, KG | 1 |
Levy, MJ | 1 |
Goadsby, PJ | 1 |
2 other studies available for methylprednisolone acetate and Atrophy
Article | Year |
---|---|
Skin and subcutanous fat atrophy after corticosteroid injection for medial epicondylitis.
Topics: Adipose Tissue; Adult; Atrophy; Elbow Joint; Female; Glucocorticoids; Humans; Methylprednisolone; Me | 2011 |
Alopecia and cutaneous atrophy after greater occipital nerve infiltration with corticosteroid.
Topics: Adipose Tissue; Adult; Alopecia; Anesthesia, Local; Anesthetics, Local; Atrophy; Female; Headache Di | 2004 |